TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Prevalence of key diseases - For key countries, 2018 4.2. New product launch 4.3. Overview of technological advancements in injectable drug delivery devices 4.4. Pricing analysis 4.5. Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018 5. Global Injectable Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Device Type 5.2.1. Conventional Injectable 5.2.2. Pre-filled Syringes 5.2.3. Auto-injectors 5.2.4. Pen-injectors 5.2.5. Wearables 5.3. Market Analysis, Insights and Forecast – By Application 5.3.1. Autoimmune Disorders 5.3.2. Diabetes 5.3.3. Pain Management 5.3.4. Aesthetic Treatments 5.3.5. Others 5.4. Market Analysis, Insights and Forecast – By Route of Administration 5.4.1. Subcutaneous 5.4.2. Intravenous 5.4.3. Intramuscular 5.4.4. Others 5.5. Market Analysis, Insights and Forecast – By End-User 5.5.1. Hospitals 5.5.2. Home Care Settings 5.5.3. Clinics 5.5.4. Others 5.6. Market Analysis, Insights and Forecast – By Region 5.6.1. North America 5.6.2. Europe 5.6.3. Asia pacific 5.6.4. Latin America 5.6.5. Middle East & Africa 6. North America Injectable Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis – By Device Type 6.2.1. Conventional Injectable 6.2.2. Pre-filled Syringes 6.2.3. Auto-injectors 6.2.4. Pen-injectors 6.2.5. Wearables 6.3. Market Analysis – By Application 6.3.1. Autoimmune Disorders 6.3.2. Diabetes 6.3.3. Pain Management 6.3.4. Aesthetic Treatments 6.3.5. Others 6.4. Market Analysis – By Route of Administration 6.4.1. Subcutaneous 6.4.2. Intravenous 6.4.3. Intramuscular 6.4.4. Others 6.5. Market Analysis – By End-User 6.5.1. Hospitals 6.5.2. Home Care Settings 6.5.3. Clinics 6.5.4. Others 6.6. Market Analysis – By Country 6.6.1. U.S. 6.6.2. Canada 7. Europe Injectable Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis – By Device Type 7.2.1. Conventional Injectable 7.2.2. Pre-filled Syringes 7.2.3. Auto-injectors 7.2.4. Pen-injectors 7.2.5. Wearables 7.3. Market Analysis – By Application 7.3.1. Autoimmune Disorders 7.3.2. Diabetes 7.3.3. Pain Management 7.3.4. Aesthetic Treatments 7.3.5. Others 7.4. Market Analysis – By Route of Administration 7.4.1. Subcutaneous 7.4.2. Intravenous 7.4.3. Intramuscular 7.4.4. Others 7.5. Market Analysis – By End-User 7.5.1. Hospitals 7.5.2. Home Care Settings 7.5.3. Clinics 7.5.4. Others 7.6. Market Analysis – By Country/Sub-Region 7.6.1. U.K. 7.6.2. Germany 7.6.3. France 7.6.4. Spain 7.6.5. Italy 7.6.6. Scandinavia 7.6.7. Rest of Europe 8. Asia pacific Injectable Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis – By Device Type 8.2.1. Conventional Injectable 8.2.2. Pre-filled Syringes 8.2.3. Auto-injectors 8.2.4. Pen-injectors 8.2.5. Wearables 8.3. Market Analysis – By Application 8.3.1. Autoimmune Disorders 8.3.2. Diabetes 8.3.3. Pain Management 8.3.4. Aesthetic Treatments 8.3.5. Others 8.4. Market Analysis – By Route of Administration 8.4.1. Subcutaneous 8.4.2. Intravenous 8.4.3. Intramuscular 8.4.4. Others 8.5. Market Analysis – By End-User 8.5.1. Hospitals 8.5.2. Home Care Settings 8.5.3. Clinics 8.5.4. Others 8.6. Market Analysis – By Country/Sub-Region 8.6.1. Japan 8.6.2. China 8.6.3. India 8.6.4. Australia 8.6.5. Southeast Asia 8.6.6. Rest of Asia Pacific 9. Latin America Injectable Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis – By Device Type 9.2.1. Conventional Injectable 9.2.2. Pre-filled Syringes 9.2.3. Auto-injectors 9.2.4. Pen-injectors 9.2.5. Wearables 9.3. Market Analysis – By Application 9.3.1. Autoimmune Disorders 9.3.2. Diabetes 9.3.3. Pain Management 9.3.4. Aesthetic Treatments 9.3.5. Others 9.4. Market Analysis – By Route of Administration 9.4.1. Subcutaneous 9.4.2. Intravenous 9.4.3. Intramuscular 9.4.4. Others 9.5. Market Analysis – By End-User 9.5.1. Hospitals 9.5.2. Home Care Settings 9.5.3. Clinics 9.5.4. Others 9.6. Market Analysis – By Country/Sub-Region 9.6.1. Brazil 9.6.2. Mexico 9.6.3. Rest of Latin America 10. Middle East & Africa Injectable Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026 10.1. Key Findings / Summary 10.2. Market Analysis – By Device Type 10.2.1. Conventional Injectable 10.2.2. Pre-filled Syringes 10.2.3. Auto-injectors 10.2.4. Pen-injectors 10.2.5. Wearables 10.3. Market Analysis – By Application 10.3.1. Autoimmune Disorders 10.3.2. Diabetes 10.3.3. Pain Management 10.3.4. Aesthetic Treatments 10.3.5. Others 10.4. Market Analysis – By Route of Administration 10.4.1. Subcutaneous 10.4.2. Intravenous 10.4.3. Intramuscular 10.4.4. Others 10.5. Market Analysis – By End-User 10.5.1. Hospitals 10.5.2. Home Care Settings 10.5.3. Clinics 10.5.4. Others 10.6. Market Analysis – By Country/Sub-Region 10.6.1. GCC Countries 10.6.2. South Africa 10.6.3. Rest of Middle East & Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2018) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 11.5.1. BD 11.5.2. SHL Group 11.5.3. Insulet Corporation 11.5.4. Elcam Medical 11.5.5. Pfizer Inc. 11.5.6. Eli Lilly and Company 11.5.7. West Pharmaceutical Services, Inc. 11.5.8. Ypsomed AG 11.5.9. Gerresheimer AG 11.5.10. Others 12. Strategic Recommendations

BD SHL Group Insulet Corporation Elcam Medical Pfizer Inc. Eli Lilly and Company West Pharmaceutical Services, Inc. Ypsomed AG Gerresheimer AG Others